Gene Prediction Tools Market Size, Share & Trends Analysis Report By Component (Software, Services), By Method (Ab- initio Prediction, Homology-based Prediction, Hybrid Gene Prediction), By Application (Diagnostics, Drug Discovery & Designing, Others), By End-User (Pharmaceuticals & Biotechnology Companies, Diagnostics Centers, Academic & Research Institutes, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Gene Prediction Tools Market Size

The global gene prediction tools market size was valued at USD 231.13 million in 2025 and is projected to grow from USD 271.72 million in 2026 to USD 991.27 million by 2034, registering a CAGR of 17.56% during the forecast period from 2026 to 2034. North America dominated the gene prediction tools market with a market share of 38.4% in 2025.

Gene prediction tools are bioinformatics software designed to identify genes within a given DNA sequence. These tools use computational algorithms to analyze genomic data, detect coding regions, and predict gene structures, including exons, introns, and regulatory elements. They rely on various approaches, such as ab initio methods, which use statistical models to identify genes based on sequence patterns, and homology-based methods, which compare sequences to known genes in databases.

A significant trend shaping the market is the growing adoption of cloud-based bioinformatics solutions, which enable efficient genomic data analysis with improved accessibility and scalability. Moreover, the integration of AI and machine learning (ML) into gene prediction is revolutionizing genome annotation by enhancing accuracy, streamlining workflows, and significantly reducing the time required for analysis.

A notable advancement in this space came in September 2023, when Deep Genomics introduced BigRNA, an AI-driven foundation model designed to enhance gene prediction. BigRNA accurately identifies tissue-specific RNA regulatory mechanisms, protein and microRNA binding sites, and the effects of genetic variants. This breakthrough strengthens the market by facilitating precise genomic analysis, accelerating the discovery of novel therapeutic targets, and advancing RNA-based drug development.

Beyond healthcare, agricultural and livestock genomics are emerging as new growth avenues, with gene prediction tools playing a crucial role in crop improvement and disease resistance. Government initiatives and funding, such as the Human Genome Project and Genome India Initiative, are further driving innovation. Moreover, strategic collaborations between biotech firms and AI-driven genomic analysis companies are expanding market opportunities, fostering innovation, and accelerating the adoption of advanced gene prediction technologies.

Component Insights

The software segment dominates the market due to the growing adoption of AI-driven algorithms, which enhance predictive accuracy and streamline genomic analysis. These provide automation, seamless integration with genomic databases, and scalability, making them essential for researchers, biotech firms, and pharmaceutical companies. Moreover, the rise of cloud-based bioinformatics platforms and open-source genomic software is driving further adoption by enabling cost-effective and accessible genomic research.

Request Customizationto receive a tailored report.

Method Insights

Ab-initio prediction dominates the global market due to its ability to analyse unknown genomic sequences without requiring prior knowledge, making it valuable for novel gene discovery. It is widely used in computational genomics and genome annotation projects. Moreover, advancements in AI and machine learning are further enhancing the accuracy and efficiency of ab-initio gene prediction models, driving their continued adoption in genomics research and personalized medicine.

Application Insights

The diagnostics segment dominates the market, driven by its increasing use in detecting genetic disorders, cancer biomarkers, and inherited diseases. The growing demand for precision medicine and early disease detection fuels adoption in clinical settings. Moreover, advancements in next-generation sequencing (NGS) and bioinformatics enhance diagnostic accuracy, supporting applications in newborn screening, rare disease identification, and predictive genetic testing for personalized treatment plans.

End-User Insights

Pharmaceutical & biotechnology companies dominate the market due to the increasing use of gene prediction tools in drug discovery, genetic therapy research, and biomarker identification. These companies leverage predictive genomics to enhance targeted therapies and streamline clinical trials. Moreover, strategic collaborations between biotech firms, research institutions, and AI companies are accelerating advancements in genomic research, fostering innovation in gene-based therapies and personalized treatment approaches.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America dominates the gene prediction tools market, driven by substantial investments in genomics research, advanced bioinformatics infrastructure, and robust government funding initiatives. The presence of key players like Illumina, Thermo Fisher Scientific, and Pacific Biosciences strengthens regional growth. Moreover, strategic collaborations between biotech firms, research institutions, and AI companies enhance innovation. The increasing integration of machine learning in genomic analysis, rising adoption of precision medicine, and expanding applications in oncology, rare disease diagnostics, and drug discovery further solidify North America’s leadership in the market.

The U.S. market is a leader due to its substantial government funding, strong presence of biotechnology and pharmaceutical companies, and high adoption of AI-driven bioinformatics. The country’s focus on precision medicine, genomic research programs, and strategic collaborations between academic institutions, healthcare providers, and tech firms drives continuous innovation, strengthening its position in the market.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific is expected to hold the highest CAGR, driven by increasing genome sequencing initiatives, rising healthcare expenditures, and rapid advancements in precision medicine. Countries like China, India, and Japan are heavily investing in large-scale genomic research projects such as the Genome India Initiative and China’s Precision Medicine Initiative. Moreover, the emergence of local bioinformatics startups, government-backed funding programs, and partnerships with global biotech firms are accelerating market expansion. Growing demand for genetic diagnostics, personalized medicine, and AI-powered genomic tools further propels Asia-Pacific’s rapid market growth.

India’s gene prediction tools market is witnessing rapid growth, driven by expanding research facilities, increasing biotech investments, and government-backed initiatives. In August 2023, Illumina Inc. launched the Illumina Solutions Centre in Bengaluru, designed to enhance sequencing capabilities, support genomic research, and foster industry collaborations. India's focus on genetic diagnostics, personalized medicine, and bioinformatics innovation is accelerating market expansion, making it a rising global hub for genomic research and precision medicine.

China’s market for gene prediction tools is experiencing significant growth, supported by strong government initiatives, rising research investments, and expanding genomic sequencing capabilities. The country’s emphasis on precision medicine, biotechnology innovation, and large-scale genome projects, such as the China Precision Medicine Initiative, is driving adoption. Moreover, China's growing bioinformatics sector, AI-powered genetic analysis, and increasing demand for personalized healthcare solutions are accelerating advancements in genomic research and medical applications.

Europe Gene Prediction Tools Market Trends

Germany is one of the largest market for gene prediction tools in Europe, driven by the expansion of new facilities and an increase in government funds and initiatives.

• For instance, in March 2024, Roche received a €90 million investment under Germany’s National Strategy for Gene and Cell Therapies to establish a gene therapy center. The facility will focus on manufacturing gene therapy vectors for clinical trials, advancing research and development in the field.

The United Kingdom’s market, is driven by significant government investments in genomics research. For instance, in December 2022, the UK government announced over £175 million in funding to advance genomics research. This initiative aims to develop the most advanced genomic healthcare system, enhancing disease prevention, early diagnosis, and personalized treatments to improve health outcomes in the country.

Canada's gene prediction tools industry is expanding due to government-backed genomic research initiatives. In October 2023, the Canadian government announced a $15 million investment to create the Pan-Canadian Genome Library aimed at seamless genomic data sharing. Supported by the Canadian Institutes of Health Research, this initiative boosts rare disease research, precision medicine advancements, and the development of genetic therapies, positioning Canada as a key player.

Company Market Share

Key players in the market are actively adopting strategic collaborations, product approvals, acquisitions, and product launches to strengthen their market presence. Companies are investing in AI-driven bioinformatics solutions, expanding genomic databases, and integrating machine learning algorithms to enhance predictive accuracy.

Verily: An Emerging Player in the Global Gene Prediction Tools Market

Verily Life Sciences, a subsidiary of Alphabet Inc., focuses on applying data science, artificial intelligence, and biomedical research to advance precision medicine and healthcare solutions. Verily is leveraging AI-driven genomic analysis, cloud-based research platforms, and strategic collaborations to enhance gene identification and biomarker discovery.

Recent Developments by Verily:

• In October 2023, Verily launched viewpoint workbench, a secure platform for unifying multimodal data and accelerating genomic research. Part of Verily Viewpoint, it enhances gene prediction tools by enabling efficient data governance and analysis, supporting biopharma and precision medicine advancements.

List of Key and Emerging Players in Gene Prediction Tools Market